{"name":"Sirtsei Pharmaceuticals, Inc.","slug":"sirtsei-pharmaceuticals-inc","ticker":"","exchange":"","domain":"sirtsei.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOOGtzUHNmN0hwalJEWHY5a0xxT0d6ajNSWU9DZTQ0Y2p0Z2piSExIN0pYTmNMUS14YWx2WmpUVVA0ekVyejlKc2diRHdSd3VFTW5MbUlTN3FKSzc4STJFenA5R1RLbDY2MUhSLVZrUjkyUXRPUXR5VXUzR2wxOVBjOWNaVmpRVVVjLTZhdEJHSjNfSmJwVFpPM0p1aFVhWU9yWmNvaXRFOWd1aUpY?oc=5","date":"2025-06-09","type":"pipeline","source":"Medscape Reference","summary":"Addressing Partial Treatment Response in MDD Patients - Medscape Reference","headline":"Addressing Partial Treatment Response in MDD Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQUHVfZnpWMzJJVzBKSjhZTkM2RUZha09VMkZSa0JMUUJubVphYm04dkZtMHdvZ1VXZHFla3VvZER6TW41REQta2RkR2piNE4yOG1kTlBQN3pNTUtWWnFNSXk3VXZxYmFkbFdSeEJtcDY0VkVKMTE1NDNpMHlFUGZ1cTB0alA2b0hlbjlVSmZiRGJOQ3ZvSFpWSjBKZTcweDZPcWxlU2dNeVMxWnB0b0hTalNlZi14eFJUcUt6UUNmNmtvSG8?oc=5","date":"2024-10-29","type":"regulatory","source":"Pharmaceutical Technology","summary":"Arrivo targets major depressive disorder in females after early efficacy data - Pharmaceutical Technology","headline":"Arrivo targets major depressive disorder in females after early efficacy data","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}